Reddit Posts
$ARMP: Creator of the Deadliest Organisms on Earth
Mentions
Why aren’t more people looking at ARMP instead?
ARMP, just got FDA support for Phase 3
My ARMP journey this year: Buy at $2.10, panic sell at $1.50, think I'm a genius when it keeps going down to $0.95. Now at $7.29.
Hopefully I can break up the BYND spam with a win I'd like to share. I haven't seen this ticker mentioned today (although I haven't been in the lounge much today due to the aforementioned spam). I bought ARMP at $3.50 at open today as I saw they had a "late-breaking" presentation today which looked very interesting based off the brief. I sold 2.5 hours later at $6.01 and I was very proud of the trade. I later saw it soar as high as 16 but a realistic sale could have occurred at 13.75. While I still consider this a win, it's quite jarring to see it still rocket after is has already rocketed. For what it's worth, I never expected ARMP to rise as much as it did or so soon, so there was still an element of luck, but the reason for entry was no luck. I have entered BOLD today at 1.50 for a similar reason as they have a presentation tomorrow, although I don't expect anywhere near the movement that ARMP had. However, I see more downside to this one as there has been a bigger runup.
$BCLI $Brainstorm Cell Therapeutics I it’s coming🚀🚀 https://www.tipranks.com/news/the-fly/biotech-alert-searches-spiking-for-these-stocks-today-thefly $ARMP $NRXS $PTIX $EYEN $NVAX
ARMP earnings are Thursday. Last chance to buy the dip.
The recent ARMP dip has been bought. Still time to get in because shares are still a 3-4 bagger from here.
Buying more ARMP before it goes way up, and its sponsor INVA. Well-funded biotech is a good long term hold through the craziness.
Assuming the funding is there, biotech is a great play now. ARMP just got funding for its new clinical trials. Bought some today, will buy more tomorrow.
ARMP just secured a sweet loan from INVA for its clinical trials, to be paid back when the money starts rolling in. No dilution. This is great news for the stock. Buy the dip.
Unusually high volume on ARMP in the last few days. A lot of shares got dumped all at once but the dip is getting bought. Something's up.
ARMP. They've got something special. Buy the dip instead of getting screwed by algos reacting to Trump's tweets.
Buy the ARMP dip. It's a steal this low with the financial backing of INVA but now trading like it's a risky start-up. It's not. Earnings are scheduled for the 19th, and it can move BIG on earnings. There's also a tiny float so you may get huge interest if you can loan out your shares.
Bullish on ARMP is the way to go today.
ARMP volume back to being above its average in the past few days, after an extended period of being way below it. Something could be happening.
ARMP. The CEO has Trump connections.
More M&A activity, tariffs on physical goods, cronyism... good time to be an investor in a biotech startup with a CEO connected to Trump. ARMP
That include DoD grants even? ARMP might be in trouble if that's the case.
My favorite buy and hold forget for 20 years picks are: CRSP and MRNA - CRSPR Cas and mRNA therapies will cure or treat like all genetic diseases TDOC - Telemedicine because we’re all scared to go outside and unhealthy as shit ARMP - Bacteriophage might be the solution for antibiotic resistance RKLB and PL - My favorite space plays MVST - EV CWCO - Water Do your own DD on these
!Banbet ARMP goes up 2 percent tomorrow at open
ARMP, new CEO and it’s up 289% within the last month.
$ARMP September 15 $2.5 puts 👀
ARMP in the house!!!!
$ARMP August 18 $2.5 put 👀
I just bought ARMP because i can call it armpit; and I like that 😌
$ARMP August 18 $2.5 put 👀
$ARMP August 18 $2.5 put 👀
Get some ARMP also brother
Rocket lab RKLB and ARMP
By the way, if you're interested in a great biotech company for short-mid-long term, check out ARMP. They're working on bacteriophage treatments, which will basically replace antibiotics in the near future.
ARMP - they are producing bacteriophages to target antibiotic resistant bacteria.
take a look at phage therapy, which is another approach. Not that many public companies around, but there are $PHGE and $ARMP
This sounds great! For something as revolutionary as this are you sure there are no other companies that do this? You said companies “entirely focused on phage therapies”, whose to say other companies (who although may not focus “entirely” on phage therapies) can also be competition in this market? Sorry for not doing my own DD but is ARMP the leader in Phage therapeutics development?